ET
Entrada Therapeutics Inc
🇺🇸XNAS.TRDAUnited StatesHealthcare
$6.90USDdown -0.15 (-2.13%)OpenEnd of day3:15 PM
Price$6.90-0.15 (-2.13%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US29384C1080
- CUSIP
- 29384C108
Company
- Employees
- 152
- Headquarters
- Boston, United States
- Website
- https://www.entradatx.com
- CEO
- Mr. Dipal Doshi
Market
- Shares outstanding
- 38.9M
- Market cap
- $268.66M
Key dates
- Next earnings
- Nov 5, 2026
Highlights
- Market cap
- $268.66M
- EPS LTM
- -$4.26calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -1.62calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $4.69M-94.1%down year on year
- Net income
- -$165.78M-126%down year on year
- Gross margin
- -754.72%-884.24%down year on year
- Free cash flow
- -$134.35M-6.16%down year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.